Literature DB >> 2851307

Genomic organization of the human spumaretrovirus and its relatedness to AIDS and other retroviruses.

B Maurer1, R M Flügel.   

Abstract

The human spumaretrovirus (HSRV) isolated from a nasopharynx carcinoma patient 17 years ago has a RNA genome 11 kb in size. It encodes besides the gag, pol, and env genes several novel genes (S1 and bel 1, 2, and 3) that are comparable to the regulatory genes R, X, tat, art, and 3'-orf of the human (HIVs) and simian immunodeficiency viruses (SIVs) with respect to genomic location and to sizes of the putative gene products. A comparison between the HIV protein sequences of the pol and the novel genes to the corresponding gene product sequences of HSRV revealed that HSRV is related to the lentiviruses but occupies a distinct phylogenetic placement of its own. A detailed analysis of the reverse transcriptase domain allows the construction of a phylogenetic tree for the known retroviral subfamilies and/or groups, including the oncoviruses, the lentiviruses, the spumaviruses, the HLTV-BLV group, and the D-type viruses. Regions of the putative novel HSRV gene products with segmental protein sequence homology to the regulatory protein of other human retroviruses are discussed. The results strengthen the view that HSRV and its novel genes should be studied in comparison to the new genes of acquired immunodeficiency syndrome (AIDS) viruses and human T cell leukemia viruses (HTLV).

Entities:  

Mesh:

Year:  1988        PMID: 2851307     DOI: 10.1089/aid.1988.4.467

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  11 in total

1.  Comparative analysis of the retroviral pol and env protein sequences reveal different evolutionary trees.

Authors:  G Lewe; R M Flügel
Journal:  Virus Genes       Date:  1990-02       Impact factor: 2.332

2.  Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product.

Authors:  L K Venkatesh; P A Theodorakis; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

3.  Characterization of the transcriptional trans activator of human foamy retrovirus.

Authors:  A Keller; K M Partin; M Löchelt; H Bannert; R M Flügel; B R Cullen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Transcriptional mapping of the 3' end of the bovine syncytial virus genome.

Authors:  R W Renshaw; J W Casey
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

5.  Electron microscopy of the nucleocapsid from disrupted Moloney murine leukemia virus and of associated type VI collagen-like filaments.

Authors:  J Pager; D Coulaud; E Delain
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

6.  Infectious DNA of the human spumaretrovirus.

Authors:  A Rethwilm; G Baunach; K O Netzer; B Maurer; B Borisch; V ter Meulen
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

7.  The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region.

Authors:  A Rethwilm; O Erlwein; G Baunach; B Maurer; V ter Meulen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

8.  Structural and evolutionary analysis of an orangutan foamy virus.

Authors:  Ernst J Verschoor; Susan Langenhuijzen; Saskia van den Engel; Henk Niphuis; Kristin S Warren; Jonathan L Heeney
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

Authors:  B Maurer; E Serfling; V ter Meulen; A Rethwilm
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  A serological survey of bovine syncytial virus in Ontario: associations with bovine leukemia and immunodeficiency-like viruses, production records, and management practices.

Authors:  R M Jacobs; F L Pollari; W B McNab; B Jefferson
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.